We are live on ! Find out more
ONCO icon

Onconetix
ONCO

5 hedge funds and large institutions have $3.23M invested in Onconetix in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

557% more capital invested

Capital invested by funds: $492K → $3.23M (+$2.74M)

0% more ownership

Funds ownership: 0% → 0% (+0%)

44% less funds holding

Funds holding: 9 → 5 (-4)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
5
Holders Change
-4
Holders Change %
-44.44%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Zurich Cantonal Bank
Zurich Cantonal Bank
Switzerland
+$3.12M
2
UBS Group
UBS Group
Switzerland
+$72K

Top Sellers

Rank Fund Capital Flow
1
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
-$53.5K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$19K
3
HF
HRT Financial
New York
-$17K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$15.9K
5
Jane Street
Jane Street
New York
-$14.6K

ONCO Hedge Fund Activity: Q3 2024 in Review

5 of the 6,977 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q3 2024, worth a combined $3.23M — up 557% from $492K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ONCO and 1 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Zurich Cantonal Bank, adding an estimated $3.12M. The largest seller was Cetera Investment Advisers, exiting entirely with an estimated $53.5K sold.

  • 5 institutional investors held Onconetix (ONCO) as of Q3 2024, down from 9 in Q2 2024.
  • Funds reported $3.23M of Onconetix stock for Q3 2024, up 557% quarter-over-quarter.
  • 1 fund opened new Onconetix positions in Q3 2024 and 5 closed out, a net change of -4 holders.
  • The largest Onconetix buyer in Q3 2024 was Zurich Cantonal Bank, an estimated $3.12M added.
  • The largest Onconetix seller in Q3 2024 was Cetera Investment Advisers, an estimated $53.5K sold.

Based on aggregated 13F filings for Q3 2024.